Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function
- 15 November 2004
- journal article
- retracted article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (22) , 8318-8327
- https://doi.org/10.1158/0008-5472.can-04-1145
Abstract
Tumor-associated mutants of the p53 tumor suppressor protein exert biological activities compatible with an oncogenic gain of function. To explore the underlying molecular mechanism, we performed microarray analysis, comparing p53-null cells to mutant p53-expressing cells. One of the genes up-regulated in the presence of mutant p53 was EGR1, a transcription factor implicated in growth control, apoptosis, and cancer. EGR1 induction by various types of stress is markedly augmented in cells expressing mutant p53. Moreover, chromatin immunoprecipitation analysis indicates that mutant p53 is physically associated with the EGR1 promoter. Functional assays indicate that induction of EGR1 by mutant p53 contributes to enhanced transformed properties and resistance to apoptosis. We propose that EGR1 is a significant contributor to mutant p53 gain of function.Keywords
This publication has 53 references indexed in Scilit:
- Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutantsOncogene, 2003
- The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cellsBiochemical Journal, 2003
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002
- Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2Cell Death & Differentiation, 2001
- The Transcription Factor EGR-1 Directly Transactivates the Fibronectin Gene and Enhances Attachment of Human Glioblastoma Cell Line U251Journal of Biological Chemistry, 2000
- EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicityOncogene, 2000
- Mutant p53 protein expression interferes with p53-independent apoptotic pathwaysOncogene, 1998
- Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formationInternational Journal of Cancer, 1997
- Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.Genes & Development, 1994
- Different Tumor-Derived p53 Mutants Exhibit Distinct Biological ActivitiesScience, 1990